Sonic Healthcare Limited SHL
ASX · Australia · Health Services
AUD 18.61-0.38 (-2.00%)
Market closed· · AUD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · AUD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
The global clinical laboratory services market was valued at USD 274.6 billion in 2025 and is forecast to reach USD 468.2 billion by 2036, rising from USD 298.4 billion in 2026 at a 4.6% CAGR. Growth is driven by chronic diseases, preventive healthcare, molecular diagnostics, genomic testing, precision medicine, laboratory automation, AI-enabled diagnostics, and at-home testing. North America leads, while Asia-Pacific is set for the fastest growth. The report analyzes key segments, regions, oppo
CellCarta, a leading global CRO laboratory to the biopharmaceutical industry, today announced a Strategic Partnership with Sonic Healthcare USA, Inc. ("SHUAS" or "Sonic") to launch the first commercial laboratory relationship in CellCarta's Lab Network strategy, designed to support commercialization of companion diagnostics developed through CellCarta's single-site PMA CDx bridging model.
Investing.com -- Australian Prime Minister Anthony Albanese announced on Sunday that the upcoming federal budget will include a significant funding boost for Medicare urgent care clinics, according to a report from Bloomberg.
For many, the main point of investing is to generate higher returns than the overall market. But even the best stock...
Key Insights The considerable ownership by individual investors in Sonic Healthcare indicates that they collectively...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.